In RCC specifically, previous studies have suggested that PDCD4 downregulation correlates with tumor progression and metastasis [21], consistent with our observation that signature scores decrease progressively with advancing tumor stage. This evidence concerns the gene PDCD4 and renal cell carcinoma.